BCMU
LH icon

BlueCrest Capital Management (UK)’s Labcorp LH Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-44,268
Closed -$3.89M – 601
2014
Q2 		$3.89M Buy
+44,268
New +$3.83M 0.13% 121

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

BlueCrest Capital Management (UK)'s LH Position: Q3 2014 in Review

BlueCrest Capital Management (UK) sold out of Labcorp (LH) in Q3 2014, closing a stake of 44,268 shares — an estimated $3.89M sold.

BlueCrest Capital Management (UK) first reported a position in LH in Q2 2014 and held it in 1 quarter. The position peaked at $3.89M in Q2 2014. 525 funds tracked by Wall St. Rank hold LH as of Q3 2014.

  • BlueCrest Capital Management (UK) reported no remaining Labcorp position as of Q3 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 44,268 Labcorp shares in Q3 2014, an estimated $3.89M.
  • BlueCrest Capital Management (UK) first reported a position in Labcorp in Q2 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Labcorp position peaked at $3.89M in Q2 2014.
  • 525 funds tracked by Wall St. Rank held Labcorp as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.